Thu, Dec 25, 2014, 12:53 PM EST - U.S. Markets closed for Christmas

Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

hhabana2112 214 posts  |  Last Activity: Dec 23, 2014 1:21 AM Member since: Oct 6, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • hhabana2112 hhabana2112 Dec 23, 2014 1:21 AM Flag

    Abeta, I think us longs are putting too much emphasis on shorts. There is a balance to the price of the stock which is buying and selling. I have seen this kind of talk of shorts effect on other stocks and the reason they may rule is that the company (any company) cannot produce compelling evidence to buy the stock. This is just a natural occurrence of events. You remember the move up to the 5's after DCVax was on Fox News? I do. There was some compelling evidence to buy the stock since that one physician brought attention to the drug. Or the breakout to 10?

    I will say it again that I'm a little concerned about this management. Looking back on a conference, why would Linda make a comment that the stock is cheap? This I found a little disconcerting. Let the company's products speak for themselves. What kind of comment is that? How is that Juno shoots up to 40 the day after IPO, but with all these stellar individual results NWBO cannot generate any interest. The technicals are awful. Even for the follow through the day after Juno. I feel this is dead money for now and these catalysts may not be what we are expecting to drive the PPS up. I hope I'm wrong, but I've whittled down my position in this stock and will sight tight for now. What is with the ambiguity regarding the payments from Germany? They, NWBO management, cannot give an estimate. Less than 50 grand or more? What's so hard about that. I'm not saying the markets are always right. I am a Peter Lynch fan, but there is something suspect and I hope the market is not right.

    Sentiment: Hold

  • hhabana2112 hhabana2112 Dec 21, 2014 2:42 AM Flag

    Are you long or short? Man up to this question. Why you here? If you are short, that's fine. Everyone has to try to make a buck.

    Other question, what do you think of this CART therapy being investigated by Juno?

  • hhabana2112 hhabana2112 Dec 21, 2014 2:05 AM Flag

    I give you a greeny for this info.

  • Reply to

    Today After Hours Trading is Very Interesting....

    by acec-stl Dec 18, 2014 5:28 PM
    hhabana2112 hhabana2112 Dec 19, 2014 9:55 AM Flag

    Yes, I agree with you that overall market contributed to this pop up along with other biotech's I follow. Regarding fundamentals I see none here as we haven't received any info. Someone here posted that Goldman was going to provide some stellar news by year end. What happened?

  • Reply to

    BCLM and JUNO IPO's

    by iphuseeku Dec 19, 2014 8:26 AM
    hhabana2112 hhabana2112 Dec 19, 2014 9:53 AM Flag

    If NWBO can't bring attention to itself with their good results then I highly doubt these companies can do much more for them. The stock is NOT impressing me technically and don't care for the lack of transparency the longer I stay here.

  • Reply to

    WOW - UP 8% - on NO VOLUME .........

    by abeta4238 Dec 17, 2014 1:40 PM
    hhabana2112 hhabana2112 Dec 18, 2014 5:21 PM Flag

    Me too. GL!

  • Reply to

    DCVax Direct - The Numbers

    by hope4patients Dec 18, 2014 12:54 PM
    hhabana2112 hhabana2112 Dec 18, 2014 5:20 PM Flag

    A 1000 per share? Ummmm, I don't see anyone in the markets seeing that and they sure aren't buying with any conviction. I don't see any breakouts on the chart. We're moving sideways between low 6 and high 4's. Technicals do not support many longs beliefs here. I wish it did. :(

    I hope LP has something good to say tomorrow! GLTA.

    Sentiment: Hold

  • hhabana2112 hhabana2112 Dec 18, 2014 11:39 AM Flag

    Good stuff and very interesting. Thanks. Now lets see the stock move. Waiting.

  • Reply to

    WOW - UP 8% - on NO VOLUME .........

    by abeta4238 Dec 17, 2014 1:40 PM
    hhabana2112 hhabana2112 Dec 17, 2014 2:05 PM Flag

    I'll take it! Anyday! On Schwab i had 30 day avg around 440,000. I think we might get to it. Not sure. It is nice to be in the 5's even if the technicals aren't the greatest. I'd like to see some bigger volume, but maybe the shareholder meeting will give us a surprise. More companies getting into immunotherapy and I'd like to see NWBO hurry up and get their vaccines approved ASAP.

  • Reply to

    Juno IPO

    by momentum2play Dec 17, 2014 10:45 AM
    hhabana2112 hhabana2112 Dec 17, 2014 1:22 PM Flag

    When is IPO? A colleague told me about this company. Lots of big money from big money people invested in this company.

  • Reply to

    About Big Pharma ....

    by abeta4238 Dec 11, 2014 1:54 PM
    hhabana2112 hhabana2112 Dec 16, 2014 2:05 PM Flag

    Abeta, that's fine and dandy, but these individual case studies are getting old. They're losing their effect. We need some concrete dates and numbers. I'm not here to sit with a big position for 5 years for the stock to move back to 7-8. Forget it. I had to pass on Blue when it was in the low 30's with the pullback we had a month and half ago. I missed out with NWBO being my core holding. I"m with you on the great technology, but am not with you on getting brainwashed by management and their tidbits of info. Not good. I'm a veteran investor/trader and have seen many of these CEO and managements do things in their own interests. I think independently and don't need anyone to agree with me. This saved me from a huge loss recently with GTAT. I took a loss in the 12-13 range and the stock later went bankrupt. There were people there that lost all there monies regardless how much they cheer leaded. I will see what Linda says this Friday. If not convincing, I will bail and keep 5-7000 shares as a Hail Mary and not worry about that small change.

  • Any thoughts? I'd like to hear some type of progress report on Germany and England. Germany in particular. Also, where we are at with these phase studies. Something a little more concrete. The individual reports of success are nice, but how about something more reflective of the whole studies under way.

    As a shareholder, we deserve to start getting some bones tossed our way. When I hear the CEO saying our stock is inexpensive, that doesn't count. That's pandering. For any technicians out there the chart is HORRIBLE. I have scaled in a little more under 5 and low 5's. That's it. Now I sit and wait for Friday.

  • Reply to

    About Big Pharma ....

    by abeta4238 Dec 11, 2014 1:54 PM
    hhabana2112 hhabana2112 Dec 12, 2014 10:07 AM Flag

    What I don't understand is if this is such a novel technology and results so stunning, I don't understand why this stock is hovering higher. I'm long on this puppy, but keeping an open mind. I'm not crazy about this downtrend again especially after presentations showing favorable results.

  • Reply to

    3D Vaccines Focusing on Dendritic Cells

    by hhabana2112 Dec 10, 2014 10:39 AM
    hhabana2112 hhabana2112 Dec 10, 2014 11:16 AM Flag

    LOL. Good one! To me this validates the use of dendritic cells and using the body's immune system (natural) to attack various illnesses.

  • This is an interesting article and gives justification to use of dendritic cells for treating cancers and so forth...

    Cancer is deadly because it is able to evade attack from the body's immune system, which allows tumors to flourish and spread. Now scientists are enlisting 3-D technology in hopes of creating a vaccine that could boost the immune system, enabling them to fight and even prevent the disease.

    Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences devised the technique.
    It involves injecting programmable biomaterial, which would spontaneously assemble inside the body into a 3-D structure that could fight and even help prevent cancer.

    So far, the researchers have tested the 3-D vaccine only in mice, but it has proven highly effective. An experiment showed that the injectable 3-D scaffold recruited and attracted millions of dendritic cells (which are messenger cells for the immune system) in a host mouse, before dispersing the cells to the lymph nodes and triggering a powerful immune response.

    "Injectable immunotherapies that use programmable biomaterials as a powerful vehicle to deliver targeted treatment and preventative care could help fight a whole range of deadly infections, including common worldwide killers like HIV and Ebola, as well as cancer," said Dr. Donald Ingber, the founding director of the Wyss Institute.

  • hhabana2112 hhabana2112 Dec 9, 2014 11:19 AM Flag

    Exactly. What else? Until then we are stuck in this trading range. I'd love to see a nice pop with convincing volume, but nothing yet.

  • hhabana2112 hhabana2112 Dec 5, 2014 11:18 AM Flag

    Good post on the science of these tumors.

  • hhabana2112 hhabana2112 Dec 5, 2014 10:05 AM Flag

    All good questions and something I will be watching. I attended a shareholder meeting of a now defunct internet company 15 years ago and I tell ya, I have seen the shareholders mostly behave as sheep (myself included) and the company provides their information for future. The interesting thing was there was one guy there that drilled the CEO and rightly so. I recall a lot of people disapproving this guy, but he was in the right. Couple of years later the company (internet services) went belly up. Same should apply to this management. I'm sticking to my guns on this one. If no news until Dec. 31st, I sell off part my position and go elsewhere. I will still hold several thousand shares as a Hail Mary as there is some positive news out there than the shorts would have us disbelieve, but I also am not going to wait forever as all these new immunotherapies are popping up. The German news is what I'm most excited about as it leads to money. Revenue. They can become a profitable company and that can fuel their other studies and expansion plans. GLTA.

  • Any guesses on what will be discussed? Got this from my broker. We need to get some hard info soon on Germany or we're going to continue this trickle downtrend.

    Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting

    NORTHWEST BIOTHERAPEUTICS, INC. Annual Meeting of Stockholders
    MEETING DATE: December 19, 2014
    For holders as of: November 14, 2014

  • hhabana2112 hhabana2112 Dec 4, 2014 10:43 AM Flag

    I wish your brother and family the best. I hope his present treatments suffice and excellent thinking about using supplements. As a pharmacist, I think too few of our health professionals put any belief into using them. I would include salmon or other low mercury fish twice a week, but stay away from the high mercury fish such as swordfish, tuna, etc. Also, read something interesting about a study where folks did exercise when getting chemo vs not, and they found the one's that exercised had better results. They hypothesized it must be the increase of blood flow transferring the chemo to the cancer cells. Fruits and veggies too. I take care of a parent with Alzheimer's and if I just went by what the neurologist recommended, she'd be dead last year easy. You have to do your research in our age of fast food medicine in America.

    Have you checked into the German treatment with DCVax? If so can you tell us what the communication is and will the Aussie government help with payments or do they (Germans) offer a discounted rate for out of country patients?

    Good luck!!!

ARNA
3.57-0.01(-0.28%)Dec 24 12:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.